{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:41:03Z","timestamp":1791474063456,"version":"4.3.4"},"reference-count":53,"publisher":"BMJ","issue":"2","funder":[{"DOI":"10.13039\/501100020171","name":"Foreign, Commonwealth and Development Office","doi-asserted-by":"publisher","award":["300055-105"],"award-info":[{"award-number":["300055-105"]}],"id":[{"id":"10.13039\/501100020171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Sex Reprod Health"],"accepted":{"date-parts":[[2022,10,22]]},"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Most cervical cancer can be prevented through routine screening. Disparities in uptake of routine screening therefore translate into disparities in cervical cancer incidence and outcomes. Transmasculine people including transgender men experience multiple barriers to cervical screening and their uptake of screening is low compared with cisgender women. Comprehensive evidence-based guidelines are needed to improve cervical screening for this group.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We searched for and synthesised clinical and programmatic guidelines for the provision of cervical screening for transmasculine patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Findings<\/jats:title>\n                  <jats:p>The guidelines offer recommendations addressing: (1) reception, check-in and clinic facilities; (2) patient data and invitation to screening; (3) improving inclusion in screening programmes; and (4) sexual history taking, language and identity. Guidelines offer strategies for alleviating physical and psychological discomfort during cervical screening and recommendations on what to do if the screening procedure cannot be completed. Most of the guidelines were from and for high-income countries.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>The evidence base is limited, but existing guidelines provide recommendations to ensure life-saving screening services are available to all who need them. We were only able to identify one set of guidelines for a middle-income country, and none for low-income countries. We encourage the involvement of transmasculine people in the development of future guidelines.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjsrh-2022-201526","type":"journal-article","created":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T13:21:59Z","timestamp":1667827319000},"page":"118-128","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Provision of cervical screening for transmasculine patients: a review of clinical and programmatic guidelines"],"prefix":"10.1136","volume":"49","author":[{"given":"Emily Jay","family":"Nicholls","sequence":"first","affiliation":[{"name":"Department of Public Health, Environments & Society, London School of Hygiene & Tropical Medicine, London, UK"},{"name":"Institute for Global Health, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6941-6539","authenticated-orcid":false,"given":"Catherine R","family":"McGowan","sequence":"additional","affiliation":[{"name":"Department of Public Health, Environments & Society, London School of Hygiene & Tropical Medicine, London, UK"},{"name":"Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Miles","sequence":"additional","affiliation":[{"name":"Department of Public Health, Environments & Society, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louisa","family":"Baxter","sequence":"additional","affiliation":[{"name":"Medical Specialties Unit, M\u00e9decins Sans Fronti\u00e8res, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Dix","sequence":"additional","affiliation":[{"name":"Department of Public Health, Environments & Society, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Rowlands","sequence":"additional","affiliation":[{"name":"Frontline AIDS, Hove, East Sussex, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4557-2358","authenticated-orcid":false,"given":"Daniel","family":"McCartney","sequence":"additional","affiliation":[{"name":"Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5529-4646","authenticated-orcid":false,"given":"Cicely","family":"Marston","sequence":"additional","affiliation":[{"name":"Department of Public Health, Environments & Society, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,11,7]]},"reference":[{"key":"2025090222025349000_49.2.118.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30293-9"},{"key":"2025090222025349000_49.2.118.2","unstructured":"Cancer Research UK . Cervical cancer incidence statistics. Oxford: Cancer Research UK, 2021. Available: https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/cervical-cancer\/incidence#heading-Two"},{"key":"2025090222025349000_49.2.118.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60551-5"},{"key":"2025090222025349000_49.2.118.4","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.479"},{"key":"2025090222025349000_49.2.118.5","unstructured":"Cancer Research UK . Cervical cancer statistics. Oxford: Cancer Research UK, 2021. Available: https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/cervical-cancer"},{"key":"2025090222025349000_49.2.118.6","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2016.290"},{"key":"2025090222025349000_49.2.118.7","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.nwh.2017.12.008","article-title":"A literature review of cervical cancer screening in transgender men","volume":"22","author":"Gatos","year":"2018","journal-title":"Nurs Womens Health"},{"key":"2025090222025349000_49.2.118.8","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1111\/jocn.13414","article-title":"Quantitative and mixed analyses to identify factors that affect cervical cancer screening uptake among lesbian and bisexual women and transgender men","volume":"25","author":"Johnson","year":"2016","journal-title":"J Clin Nurs"},{"key":"2025090222025349000_49.2.118.9","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-013-2753-1"},{"key":"2025090222025349000_49.2.118.10","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1089\/trgh.2016.0032","article-title":"An exploratory study of transgender new Yorkers' use of sexual health services and interest in receiving services at planned parenthood of new York City","volume":"1","author":"Porsch","year":"2016","journal-title":"Transgend Health"},{"key":"2025090222025349000_49.2.118.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2017.11.009"},{"key":"2025090222025349000_49.2.118.12","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.16503"},{"key":"2025090222025349000_49.2.118.13","doi-asserted-by":"publisher","DOI":"10.3399\/BJGP.2020.0905"},{"key":"2025090222025349000_49.2.118.14","unstructured":"Public Health England (PHE) . Cervical screening: implementation guide for primary HPV screening. London: PHE, 2019. Available: https:\/\/www.gov.uk\/government\/publications\/cervical-screening-primary-hpv-screening-implementation\/cervical-screening-implementation-guide-for-primary-hpv-screening"},{"key":"2025090222025349000_49.2.118.15","unstructured":"Family Planning NSW . Implementing the changes to the National Cervical Screening Program: a guide for clinicians. Sydney: FPNSW, 2017."},{"key":"2025090222025349000_49.2.118.16","unstructured":"Baker P , Kelly D , Medeiros R . Viral protection: achieving the possible - a four step plan for eliminating HPV cancers in Europe. Brussels: European Cancer Organisation, 2020."},{"key":"2025090222025349000_49.2.118.17","unstructured":"World Health Organization . WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention. Second edition: Use of mRNA tests for human papillomavirus (HPV). Geneva: WHO, 2021."},{"key":"2025090222025349000_49.2.118.18","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1080\/13691058.2021.1952307","article-title":"Navigating trans visibilities, trauma and trust in a new cervical screening clinic","volume":"24","author":"Gibson","year":"2022","journal-title":"Cult Health Sex"},{"key":"2025090222025349000_49.2.118.19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2020.106071","article-title":"Barriers and facilitators to cervical cancer screening among transgender men and non-binary people with a cervix: a systematic narrative review","volume":"135","author":"Connolly","year":"2020","journal-title":"Prev Med"},{"key":"2025090222025349000_49.2.118.20","doi-asserted-by":"crossref","DOI":"10.1177\/1557988320925691","article-title":"Bridging barriers to cervical cancer screening in transgender men: a scoping review","volume":"14","author":"Dhillon","year":"2020","journal-title":"Am J Mens Health"},{"key":"2025090222025349000_49.2.118.21","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2020-001860"},{"key":"2025090222025349000_49.2.118.22","doi-asserted-by":"crossref","unstructured":"Graham R , Mancher M , Wolman DM , et al , eds. Clinical Practice Guidelines we can Trust. Washington, DC: The National Academies Press, 2011.","DOI":"10.17226\/13058"},{"key":"2025090222025349000_49.2.118.23","unstructured":"McGowan C , Nicholls E , McCartney D . Sexual and reproductive health service considerations for people of diverse sexual orientation, gender identity and expression, and sex characteristics (SOGIESC): a systematic review protocol, 2021. New York: PROSPERO. Available: https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD42021248851"},{"key":"2025090222025349000_49.2.118.24","unstructured":"Center of Excellence for Transgender Health . Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People. Department of Family & Community Medicine. San Francisco: University of California, 2016."},{"key":"2025090222025349000_49.2.118.25","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1097\/AOG.0000000000004294","article-title":"Health care for transgender and gender diverse individuals: ACOG Committee Opinion, Number 823","volume":"137","year":"2021","journal-title":"Obstet Gynecol"},{"key":"2025090222025349000_49.2.118.26","unstructured":"Peitzmeier S . Promoting cervical cancer screening among lesbians and bisexual women. The Fenway Institute; 2013, 2016."},{"key":"2025090222025349000_49.2.118.27","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1007\/s11606-015-3462-8","article-title":"Cervical cancer screening for patients on the female-to-male spectrum: a narrative review and guide for clinicians","volume":"30","author":"Potter","year":"2015","journal-title":"J Gen Intern Med"},{"key":"2025090222025349000_49.2.118.28","unstructured":"Rollston R . Promoting cervical cancer screening among female-to-male transmasculine patients The Fenway Institute; 2019. https:\/\/fenwayhealth.org\/wp-content\/uploads\/TFIP-28_TransMenCervicalCancerScreeningBrief_web.pdf"},{"key":"2025090222025349000_49.2.118.29","unstructured":"New York State Department of Health AIDS Institute Clinical Guidelines Program . Medical Care Criteria Committee: cervical screening for dysplasia and cancer. New York New York State Department of Health AIDS Institute; 2018 [Accessed 15 January 2021]."},{"key":"2025090222025349000_49.2.118.30","unstructured":"Thompson J , Hopwood RA , deNormand S . Medical care of trans and gender diverse adults. Fenway Institute; 2021. https:\/\/fenwayhealth.org\/wp-content\/uploads\/Medical-Care-of-Trans-and-Gender-Diverse-Adults-Spring-2021-1.pdf"},{"key":"2025090222025349000_49.2.118.31","unstructured":"Australian Government Department of Health . Toolkit for engaging under-screened and never-screened women in the National Cervical Screening Program; 2017. https:\/\/www.health.gov.au\/sites\/default\/files\/documents\/2020\/12\/national-cervical-screening-program-toolkit-for-engaging-under-screened-and-never-screened-women.pdf"},{"key":"2025090222025349000_49.2.118.32","unstructured":"Cancer Institute New South Wales . Cancer screening and primary care: a quality improvement toolkit; 2019. https:\/\/www.cancer.nsw.gov.au\/what-we-do\/working-with-primary-care\/cancer-screening-and-primary-care-quality-improvem"},{"key":"2025090222025349000_49.2.118.33","unstructured":"Beere D , Bracewell S , Crow M , et al . BASHH recommendations for integrated sexual health services for trans, including non-binary, people. British Association for Sexual Health and HIV, 2019. Available: http:\/\/www.gpone.wales.nhs.uk\/sitesplus\/documents\/1000\/bashh-recommendations-for-integrated-sexual-health-services-for-trans-including-non-binary-people-2019pdf.pdf"},{"key":"2025090222025349000_49.2.118.34","unstructured":"Primary Care Women\u2019s Health Forum . Tips for cervical screening in transgender, non-binary and intersex communities, 2020."},{"key":"2025090222025349000_49.2.118.35","unstructured":"Carter O , Verney C . Cervical screening in trans men and non-binary people with a cervix: guidance for primary care. London: RM Partners West London Cancer Alliance; 2021. https:\/\/rmpartners.nhs.uk\/wp-content\/uploads\/2022\/02\/Cervical-Screening-in-trans-men-and-non-binary-people-with-a-cervix-FINAL.pdf"},{"key":"2025090222025349000_49.2.118.36","unstructured":"Singh S . Guidelines for healthcare providers on trans-competent healthcare services for transgender patients. Asia Pacific Transgender Network; 2021. https:\/\/weareaptn.org\/wp-content\/uploads\/2021\/01\/KPRA-HCP-Factsheet_Final_19Nov2020.pdf"},{"key":"2025090222025349000_49.2.118.37","unstructured":"NHS England . NHS gives women human papillomavirus virus (HPV) home testing kits to cut cancer deaths, 2021. Available: https:\/\/www.england.nhs.uk\/2021\/02\/nhs-gives-women-hpv-home-testing-kits-to-cut-cancer-deaths\/"},{"key":"2025090222025349000_49.2.118.38","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l1357"},{"key":"2025090222025349000_49.2.118.39","unstructured":"Australian Government Department of Health and Aged Care . Self collection to increase choice within the National Cervical Screening Program, 2022. Available: https:\/\/www.health.gov.au\/news\/self-collection-to-increase-choice-within-the-national-cervical-screening-program"},{"key":"2025090222025349000_49.2.118.40","unstructured":"European Cancer Organisation (ECO) . Recommendations on screening, 2021. Available: https:\/\/www.europeancancer.org\/2-standard\/114-recommendations-on-screening-a-four-step-plan-for-eliminating-hpv-cancers-in-europe"},{"key":"2025090222025349000_49.2.118.41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0190172"},{"key":"2025090222025349000_49.2.118.42","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k4823"},{"key":"2025090222025349000_49.2.118.43","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1089\/lgbt.2016.0187","article-title":"Cervical cancer screening preferences among trans-masculine individuals: patient-collected human papillomavirus vaginal swabs versus provider-administered Pap tests","volume":"4","author":"McDowell","year":"2017","journal-title":"LGBT Health"},{"key":"2025090222025349000_49.2.118.44","doi-asserted-by":"publisher","DOI":"10.1007\/s10508-014-0314-2"},{"key":"2025090222025349000_49.2.118.45","doi-asserted-by":"publisher","DOI":"10.1136\/amiajnl-2012-001472"},{"key":"2025090222025349000_49.2.118.46","doi-asserted-by":"publisher","DOI":"10.1215\/00703370-8976151"},{"key":"2025090222025349000_49.2.118.47","doi-asserted-by":"publisher","DOI":"10.1136\/qshc.2009.032961"},{"key":"2025090222025349000_49.2.118.48","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c4078"},{"key":"2025090222025349000_49.2.118.49","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1177\/1049732317725513","article-title":"\"It can promote an existential crisis\": factors influencing Pap test acceptability and utilization among transmasculine individuals","volume":"27","author":"Peitzmeier","year":"2017","journal-title":"Qual Health Res"},{"key":"2025090222025349000_49.2.118.50","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.21037\/tau-20-954","article-title":"Cancer screening in the transgender population: a review of current guidelines, best practices, and a proposed care model","volume":"9","author":"Sterling","year":"2020","journal-title":"Transl Androl Urol"},{"key":"2025090222025349000_49.2.118.51","unstructured":"The Global Health Observatory . Type of national cervical cancer screening program. World Health Organization, 2021. Available: https:\/\/www.who.int\/data\/gho\/data\/indicators\/indicator-details\/GHO\/type-of-national-cervical-cancer-screening-program"},{"key":"2025090222025349000_49.2.118.52","unstructured":"Jo\u2019s Cervical Cancer Trust . The differing understanding of cervical screening among white women and women from a Black, Asian and Minority Ethnic (BAME) community. London Jo\u2019s Cervical Cancer Trust; 2019. https:\/\/www.jostrust.org.uk\/sites\/default\/files\/bme_research_2011_final.pdf"},{"key":"2025090222025349000_49.2.118.53","unstructured":"Timoney MT , Atrio JM . Screening for cervical dysplasia and cancer in adults with HIV. Baltimore: Johns Hopkins University, 2022."}],"container-title":["BMJ Sexual &amp; Reproductive Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjsrh-2022-201526","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T05:03:14Z","timestamp":1756875794000},"score":1,"resource":{"primary":{"URL":"https:\/\/jfprhc.bmj.com\/lookup\/doi\/10.1136\/bmjsrh-2022-201526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,7]]},"references-count":53,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,4,11]]},"published-print":{"date-parts":[[2023,4]]}},"alternative-id":["10.1136\/bmjsrh-2022-201526"],"URL":"https:\/\/doi.org\/10.1136\/bmjsrh-2022-201526","relation":{},"ISSN":["2515-1991","2515-2009"],"issn-type":[{"value":"2515-1991","type":"print"},{"value":"2515-2009","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,7]]}}}